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Four methods for measuring serum cholinesterase activity have been applied to sera of normal individuals and of patients shown to be sensitive to short-acting muscle relaxants of the succinyldicholine type. They have been assessed according to their ability to differentiate between sensitive and insensitive individuals on the basis of enzyme activity measurements alone. The method described, based upon that of Dietz 
Methods

Blood Samples
Specimens of serum have been obtained from patients in the Bristol and Leeds areas of the United Kingdom who were suspected of having a prolonged reaction to succinylcholine.
Where a genetic abnormality has been established, it has been the practice to examine as many close relatives as possible, and specimens from these individuals have been included. Except for some patients investigated in the immediate postpartum period, no specimens have been included from individuals known to suffer from any pathological condition likely to affect serum cholinesterase, such as liver disease or poisoning with organophosphate.
Blood was taken from an antecubital vein and allowed to clot. After separation, the serum was stored at -20 #{176}C. Under such conditions of storage, cholinesterase activity has been shown to be constant for several years.
Measurement of Enzyme Activity
Benzoylcholine.
This assay was done as described by Kalow and Lindsay (12) . Measurements 
Butyryithiocholine.
The method reported by Das and Liddell (9) was used with the following modifications:
200 il of a 50-or 100-fold dilution of serum in buffer instead of 10 il of undiluted serum; 500 il of 45 mmol/litre butyrylthiocholine iodide instead of 100 il of 225 mmol/litre butyrylthiocholine iodide; and 2.3 ml of 0.27 mmol/litre 5,5'-dithiobis(2-nitrobenzoate) (DTNB) instead of 2.9 ml as described by Das and Liddell. The fmal enzyme-substrate volume, 3 ml, was the same as originally reported. Activity was measured at 408 nm and 25 #{176}C in an SP1800 spectrophotoxneter.
Acetylcholine.
The method of ,Johnson and Whitehead (7) was used, based upon the time taken for the pH of an enzyme substrate mixture to decline from 7.5 to 7.3 in the Astrup micro equipment.
Propionyithiocholine
We have used the Selected Method of Dietz et aL (10) with two modifications, since the method as originally described showed an inconveniently high sensitivity. The assay temperature was reduced to 25 #{176}C and the volume of diluted serum reduced from 1000 to 500 iL The fmal volume, 5 ml, was achieved by increasing the volume of DTNB solution from 3 to 3.5 ml. These modifications diminished the rate of increase in absorbance for EYhomozygotes from a mean value of 0.25 units per minute to 0.07 units per minute. This enabled 10 measurements to be made at 1-mm intervals, thus increasing the accuracy of calculation of the rate of absorbance change without exceeding the capacity of the spectrophotometer.
Dibucaine
and fluoride inhibition. Dibucaine and fluoride numbers were measured by the methods of Kalow and Genest (13) and Harris and Whittaker (14), respectively. Genotypes were established on the basis of inhibitor numbers.
Patients.
Patients were subdivided according to genotype. Since it can be extremely difficult to be certain of an E?E genotype, even with the aid of extensive family studies, patients with enzyme which is usual in type, and where investigation of the families has been impossible or proved unhelpful, have been included in the EYE? group. All patients in groups E?E?, E?E, EE?, and E?E? have been regarded as succinylcholine-sensitive, regardless of whether this has been confirmed clinically. Likewise, all members of groups EYE?, EYE?, E?E, and EYE? have been considered as succinylcholine-insensitive unless it has been proven to the contrary or unless they have been shown to have lower enzyme activity than an affected relative in the same group. This latter qualification Das (15) , it is unlikely that more than two of the patients examined would fall into this category.
Results
The activities of the 250 specimens analyzed are shown in Figure 1 for benzoylcholine, Figure 2 for butyrylthiocholine, Figure 3 for acetylcholine, and Figure 4 for propionylthiocholine. All specimens were analyzed in duplicate and mean values are reported. The standard deviations of the differences between duplicates are shown for each method in Table 2 . Table 2 summarizes the statistical evaluation of the EYE? group for the four substrates used. We constructed probability See sublegend to Fig. 1 between patients likely to be sensitive and those who are not. propionylthiochollne and butyrylthiochollne as substrates the greaterwill be the difference in percentage inhibition between individuals homozygous for the usual enzyme form, and those heterozygous for the usual and either the atypical or fluoride-resistant forms. Thus, the method described by Zapf and Coghlan (11), using a-naphthyl acetate, gives an even better differentiation between EYE? and EYE? patients than does Kalow and Lindsay's method (12) , simply because the substrate is hydrolyzed at the same rate by both normal and atypical enzyme forms.
Note that the findings reported here for propionyl-and butyrylthiocholine are not in agreement with the work of Prellwitz et al. (18) . They showed very little difference between the two substrates, but we have demonstrated significantly higher activities against butyrylthiocholine than against the propionyl compound ( Figure 6 ). Temperature of assay is important here (3) . Probably the divergence between their results and ours is due to differences in substrate concentra- Fisher's exact test), but comparison of propionyl-and butyrylthiochoiine does achieve significance (P = 0.04).
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tion. Prellwitz used a final butyrylthiocholine concentration of only 6 mmol/litre, in contrast to our 7.5 mmol/litre, the optimum for the usual enzyme (9), while their use of propionylthiocholine involved a final concentration fivefold the 4 mmol/litre described by Dietz et al. (10) , and used here.
It can be concluded therefore from our data that considerable useful information can be derived from the simple measurement of serum cholinesterase activity, if the substrate is chosen carefully and if an appropriate dividing line is drawn between succinylcholine-sensitive and -insensitive individuals.
We have shown that by use of a value 2.5 standard deviations below the mean normal activity for E? homozygotes, as measured with propionylthiocholine, in excess of 90% of sensitive individuals are readily identified, while only 0.5% of E? homozygotes would be expected to have activities below this figure. Slightly inferior results can be obtained by use of acetylcholine and butyrylthiocholine.
Possibly these figures can even be improved upon at a risk of including succinylcholine-insensitive patients. However, it is also possible that the individuals with low serum cholinesterase activity, whom we have labeled insensitive, might prove not to be so if they should ever be exposed to short-acting muscle relaxants. Should other workers therefore choose to divide the populations at higher values than we have chosen, then the data reported here will be of value in deciding just where that dividing line should be.
In addition, those workers who wish to screen hospital populations for succinylcholine sensitivity might prefer to use the propionylthiocholine method described here rather than resort to the expensive and time-consuming methods based upon the determination of genotype by measurement of inhibitor numbers, even though only one susceptible person in about 1500 will be found.
